Role of FDG-PET/CT in Diagnosis, Staging, Response to Treatment, and Prognosis of Pancreatic Cancer
Phase II Study of Radiation Therapy Combined With Weekly Low-Dose Gemcitabine for Locally Advanced, Unresectable Pancreatic Cancer
Adjuvant Chemotherapy Among Medicaid-Enrolled Patients Diagnosed With Nonmetastatic Colon Cancer
Clinical Outcomes of Sorafenib Treatment in Patients With Metastatic Hepatocellular Carcinoma Who Had Been Previously Treated With Fluoropyrimidine Plus Platinum-based Chemotherapy
A Risk Score System to Preoperatively Predict TNM Stages in Gastric Cancer
Squamous Cell Cancer of the Anal Canal in HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy
Role of Androgen Deprivation Treatment in Patients With Castration-Resistant Prostate Cancer, Receiving Docetaxel-Based Chemotherapy
An Interobserver Study of Prostatic Fossa Clinical Target Volume Delineation in Clinical Practice
A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Carcinoma
Phase II Trial of Oxaliplatin and Capecitabine After Progression to First-Line Chemotherapy in Androgen-Independent Prostate Cancer Patients
Chemotherapy Significantly Increases the Risk of Radiation Pneumonitis in Radiation Therapy of Advanced Lung Cancer
Concurrent Cetuximab With Stereotactic Body Radiotherapy for Recurrent Squamous Cell Carcinoma of the Head and Neck
A Phase 1 Safety Study of an IRX-2 Regimen in Patients With Squamous Cell Carcinoma of the Head and Neck
Melanoma
Rectal Dose Constraints for Intensity Modulated Radiation Therapy of the Prostate
Abstracts of Oral and Poster Presentations at the 21st Annual Meeting of the American College of Radiation Oncology